Compositions and methods for cell dedifferentiation and tissue regeneration
CA 2506683 A1 · Owner: Poss, Kenneth D. · Inventors: Keating, Mark T.; Poss, Kenneth D.; Odelberg, Shannon J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods and compositions to dedifferentiate a cell. The ability of the methods and compositions off the present invention to promote the dedifferentiation of differentiated cells including terminally , differentiated cells can be used to promote regeneration of tissues and organs in vivo. The ability of the methods and compositions of the present invention to promote the dedifferentiation of differentiated cells including , terminally differentiated cells can further be used to produce populations of stem or progenitor cells which can be used to promote regeneration of tissues and/or organs damaged by injury or disease. Accordingly the present invention …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 21, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 21, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 21, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.